Iteos Therapeutics Stock Technical Analysis
| ITOS Stock | USD 8.55 0.01 0.12% |
As of the 1st of December, Iteos Therapeutics retains the Standard Deviation of 4.44, market risk adjusted performance of (0.70), and Risk Adjusted Performance of (0.15). Iteos Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Iteos Therapeutics mean deviation and maximum drawdown to decide if Iteos Therapeutics is priced fairly, providing market reflects its last-minute price of 8.55 per share. Given that Iteos Therapeutics has information ratio of (0.24), we strongly advise you to confirm Iteos Therapeutics's regular market performance to make sure the company can sustain itself at a future point.
Iteos Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Iteos, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to IteosIteos |
Iteos Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 39.5 | Strong Buy | 6 | Odds |
Most Iteos analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Iteos stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Iteos Therapeutics, talking to its executives and customers, or listening to Iteos conference calls.
Iteos Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Iteos Therapeutics Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Iteos Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Iteos Therapeutics Trend Analysis
Use this graph to draw trend lines for Iteos Therapeutics. You can use it to identify possible trend reversals for Iteos Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Iteos Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Iteos Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Iteos Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.1 , which may suggest that Iteos Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 361.03, which is the sum of squared deviations for the predicted Iteos Therapeutics price change compared to its average price change.About Iteos Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Iteos Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Iteos Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Iteos Therapeutics price pattern first instead of the macroeconomic environment surrounding Iteos Therapeutics. By analyzing Iteos Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Iteos Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Iteos Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 3.32 | 188.37 | 197.79 | PTB Ratio | 1.05 | 0.68 | 0.65 |
Iteos Therapeutics December 1, 2024 Technical Indicators
Most technical analysis of Iteos help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Iteos from various momentum indicators to cycle indicators. When you analyze Iteos charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.15) | |||
| Market Risk Adjusted Performance | (0.70) | |||
| Mean Deviation | 2.67 | |||
| Coefficient Of Variation | (471.73) | |||
| Standard Deviation | 4.44 | |||
| Variance | 19.67 | |||
| Information Ratio | (0.24) | |||
| Jensen Alpha | (1.12) | |||
| Total Risk Alpha | (1.69) | |||
| Treynor Ratio | (0.71) | |||
| Maximum Drawdown | 33.24 | |||
| Value At Risk | (4.52) | |||
| Potential Upside | 4.27 | |||
| Skewness | (3.06) | |||
| Kurtosis | 19.64 |
Additional Tools for Iteos Stock Analysis
When running Iteos Therapeutics' price analysis, check to measure Iteos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Iteos Therapeutics is operating at the current time. Most of Iteos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Iteos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Iteos Therapeutics' price. Additionally, you may evaluate how the addition of Iteos Therapeutics to your portfolios can decrease your overall portfolio volatility.